MoreTrials

MoreTrials: A public campaign to make it much easier to do randomised trials

You are here: Home / Archives for Tim Sprosen

Feb 18 2016

News: Clinical studies in dire need of new rules

Knack Be Ravinetto

Raffaella Ravinetto, a supporter of the MoreTrials campaign and a co-signatory of our recent letter to the ICH and EMA, recently featured in Knack.be, the online version of a Belgian news magazine.

[Read more…]

Written by Tim Sprosen · Categorized: News Post

Feb 10 2016

Trials that matter: One reason why most people now live after a heart-attack

Streptokinase

This is streptokinase. It was first isolated from bacteria in the 1930s and in the lab was shown to breakdown blood clots (by converting plasminogen to plasmin). When a purified version became available in the 1950s there was great interest to find out if it might increase survival if given after a person had suffered a heart-attack. This resulted in the first randomised trials being undertaken at the end of the 1950s, so what did they show? If streptokinase was given after a person had a heart-attack was survival increased?

[Read more…]

Written by Tim Sprosen · Categorized: Trials that matter Post

Feb 01 2016

Fundamental Problems with ICH-GCP: #1 Things that don’t really matter – collecting “high-quality” data

 

One thing that ICH-GCP emphasises is collecting “high-quality” data. It then goes on to spell out the considerable efforts that are required to achieve this focusing on having complete data and having that data verified against the patient’s medical notes. This is usually done by the trial sponsor sending a trained person called a monitor (aka CRA, Clinical Research Associate) to the site, say a hospital, to track down the missing data and to compare the data collected in the trial with the original data recorded in the patient’s notes. These are done every few months so not surprisingly these monitoring visits are a major cost component of the trial along with all of the other checking of data that is involved. Again, it sounds sensible doesn’t it? But, it’s not.

[Read more…]

Written by Tim Sprosen · Categorized: Fundamental problems with ICH-GCP Post

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14

A public campaign for more, better, randomised trials

Pages

  • About us
  • The Problem
    • ICH
    • ICH-GCP guideline
    • Response from ICH
    • ICH’s GCP Renovation Project
    • Stories to Highlight the Problems
  • The Solution
    • The Plan: Joint Funder Initiative
    • Developing the New-GCP
  • News
  • The unique value of randomised trials
    • Quotes
    • Illustration
    • The wider context
    • CTTI: Making things better
    • Stories of Trials That Matter
  • Supporters: Organisations
  • Supporters: Trialists
    • AllTrials
  • Videos
  • Join us
  • Contact us

Join over 260 trialists from around 35 countries

Search Form

  • Google+
  • Twitter

© 2021 Moretrials.net · Rainmaker Platform